Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Danggui Liuhuang Tang is a traditional Chinese herbal formula composed of seven herbs: Angelica sinensis (Danggui), Astragalus membranaceus (Huangqi), Rehmannia glutinosa (Shengdihuang and Shudihuang), Phellodendron amurense (Huangbai), Coptis chinensis (Huanglian), and Scutellaria baicalensis (Huangqin). It has a long history of use in traditional Chinese medicine (TCM) for treating yin deficiency with internal heat, which clinically manifests as night sweats and hot flashes. Currently, it is being evaluated in Phase II/III clinical trials by the Chang Gung Medical Foundation in Taiwan for the relief of chemotherapy-induced side effects, specifically hot flashes and menopausal-like symptoms, in breast cancer patients receiving adjuvant chemotherapy. The formula is thought to exert its effects through a complex interplay of phytochemicals that may modulate thermoregulation and hormonal balance, although specific molecular biological targets have not been definitively identified in the context of these clinical trials.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Danggui Liuhuang Tang.